Laura Calabresi Selected Research

Laura Calabresi Research Topics

Disease

21	Atherosclerosis 03/2021 - 09/2002
19	Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency) 01/2022 - 06/2004
13	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 02/2003
10	Dyslipidemias (Dyslipidemia) 01/2021 - 05/2008
8	Hypoalphalipoproteinemias (Hypoalphalipoproteinemia) 11/2013 - 02/2002
5	Hypercholesterolemia 01/2021 - 09/2005
5	Primary Myelofibrosis (Myelosclerosis) 01/2021 - 11/2017
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 01/2014
4	Acute Coronary Syndrome 01/2019 - 10/2003
4	Coronary Disease (Coronary Heart Disease) 06/2016 - 06/2002
4	Amyloidosis 01/2015 - 05/2004
4	Ischemia 02/2008 - 02/2003
4	Reperfusion Injury 09/2006 - 02/2003
3	Kidney Diseases (Kidney Disease) 01/2022 - 01/2021
3	Myocardial Infarction 01/2021 - 02/2013
3	Essential Thrombocythemia 01/2021 - 01/2019
3	Neoplasms (Cancer) 01/2021 - 11/2017
3	Anemia 05/2020 - 07/2011
3	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 12/2019 - 01/2018
3	ST Elevation Myocardial Infarction 01/2019 - 01/2009
3	Coronary Artery Disease (Coronary Atherosclerosis) 12/2016 - 04/2003
3	Familial Amyloidosis (Hereditary Amyloidosis) 01/2015 - 05/2004
3	Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial) 05/2008 - 02/2004
3	Heart Neoplasms 02/2008 - 02/2003
3	Necrosis 02/2008 - 02/2003
3	Atherosclerotic Plaque (Atheroma) 12/2006 - 03/2006
2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2019
2	Homozygous Familial Hypercholesterolemia 01/2021 - 01/2017
2	Chronic Renal Insufficiency 01/2021 - 07/2020
2	Non-alcoholic Fatty Liver Disease 12/2020 - 12/2019
2	Inflammation (Inflammations) 11/2017 - 10/2017
2	Hypertriglyceridemia 11/2015 - 06/2010
2	Hepatocellular Carcinoma (Hepatoma) 09/2013 - 03/2004
2	Corneal Opacity 12/2012 - 07/2011
2	Cholesteryl Ester Transfer Protein Deficiency 07/2012 - 02/2002
2	Hypobetalipoproteinemias (Hypobetalipoproteinemia) 05/2012 - 02/2012
2	Myocardial Ischemia (Ischemic Heart Diseases) 09/2006 - 01/2004
1	Abdominal Obesity 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Gliosis 12/2021
1	Albuminuria 01/2021
1	Infarction (Infarctions) 01/2021
1	Polycythemia Vera 01/2021
1	Non-ST Elevated Myocardial Infarction 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 05/2020
1	Cytopenia 05/2020
1	Splenomegaly 05/2020

Drug/Important Bio-Agent (IBA)

30	CholesterolIBA 01/2022 - 02/2002
23	LipidsIBA 01/2022 - 02/2003
22	HDL LipoproteinsIBA 01/2021 - 02/2003
19	HDL CholesterolIBA 01/2021 - 03/2006
15	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2021 - 02/2003
14	Lipoproteins (Lipoprotein)IBA 01/2022 - 02/2004
12	Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA 01/2021 - 06/2004
12	oxidized low density lipoproteinIBA 01/2021 - 04/2003
9	EnzymesIBA 01/2020 - 05/2006
8	ApolipoproteinsIBA 01/2021 - 09/2002
7	LDL CholesterolIBA 01/2020 - 08/2006
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 02/2005
4	Apolipoproteins B (ApoB)IBA 01/2022 - 05/2012
4	Triglycerides (Triacylglycerol)IBA 01/2022 - 02/2005
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2009
4	Pharmaceutical PreparationsIBA 05/2020 - 03/2006
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2004
3	Cholesterol Esters (Cholesteryl Esters)IBA 01/2022 - 10/2015
3	Apolipoproteins E (ApoE)IBA 01/2021 - 01/2013
3	Apolipoprotein A-II (Apolipoprotein A2)IBA 01/2017 - 05/2004
3	Niacin (Nicotinic Acid)FDA LinkGeneric 11/2015 - 09/2013
3	Fenofibrate (CiL)FDA LinkGeneric 11/2015 - 06/2010
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2013 - 02/2005
3	Creatine Kinase (Creatine Phosphokinase)IBA 02/2008 - 02/2003
2	CER-001IBA 01/2022 - 01/2021
2	Cholesterol Ester Transfer ProteinsIBA 03/2021 - 07/2012
2	red yeast riceIBA 01/2021 - 01/2014
2	CalreticulinIBA 01/2021 - 01/2019
2	BMS201038IBA 01/2021 - 01/2017
2	CytokinesIBA 01/2020 - 01/2016
2	Sterol Esterase (Hormone-Sensitive Lipase)IBA 12/2019 - 10/2015
2	Blood Proteins (Serum Proteins)IBA 01/2019 - 05/2004
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2019 - 03/2006
2	Cell Adhesion MoleculesIBA 01/2017 - 11/2007
2	Nonsense Codon (Nonsense Mutation)IBA 07/2012 - 04/2003
2	Amyloid (Amyloid Fibrils)IBA 06/2011 - 12/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2008 - 02/2003
2	apolipoprotein A-I MilanoIBA 11/2007 - 02/2007
2	Apoprotein(a) (Apolipoprotein (a))IBA 09/2006 - 03/2006
2	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2004 - 02/2003
1	Sterol O-Acyltransferase 2IBA 01/2022
1	OxysterolsIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021
1	LigandsIBA 01/2021
1	Thrombopoietin ReceptorsIBA 01/2021
1	Erythropoietin FDA Link 01/2021

Therapy/Procedure

8	Therapeutics 01/2021 - 02/2003
2	Blood Component Removal (Apheresis) 01/2021 - 01/2017
2	Injections 09/2006 - 03/2006
1	Splenectomy 05/2020